Anika Therapeutics, Inc. (ANIK)
ANIKNASDAQ-GSMedical/Dental Instruments
$13.40
-0.4100 (-2.97%) today
Closed, Nov 13, 4:00 PM ET
- Market cap
- $179.50m
- P/E
- 74.4
- EPS, last 4 quarters
- $0.1800
- Dividend yield
- –
- Day range
- –
- 52-week range
- $9.01 to $22.88
- Average volume
- –
- Previous close
- $13.81
Analysts
2 coveringBuy2 buy, 0 hold, 0 sell
Targets a year out average $23.00, +71.6% from here
Earnings
next estimate $0.0400Next report
Dec 2025
+168.4%
Mar 2026
-14.3%
Jun 2026
+257.9%
Sep 2026
-150.0%
estimate reported, and the surprise
Financials
| Quarter | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|
| Revenue | $30.61m | $29.61m | $32.61m | $30.59m |
| Gross profit | $19.18m | $19.00m | $21.24m | $18.84m |
| Operating income | $646.0k | -$5.49m | $2.95m | -$712.0k |
| Net income | $292.0k | -$5.06m | $3.31m | -$311.0k |
Last four quarters: revenue $123.43m, margin -1.4%, free cash flow $2.29m
News
8 latest- Anika Therapeutics Q3 Revenue Rises 10%; Raises 2026 Outlook RTTNews · 5 days ago
- Anika Therapeutics (ANIK) Q3 2026 Earnings Call TranscriptThe Motley Fool · Nov 6, 2026
- Anika Therapeutics Reports Third Quarter 2026 Revenue of $30.6 millionFintel · Nov 6, 2026
- What Anika Therapeutics (ANIK) Said on Its Q3 Earnings CallMarketBeat · Nov 6, 2026
- Anika Therapeutics (ANIK) Beats Q3 Earnings and Revenue EstimatesZacks · Nov 6, 2026
- Regenxbio (RGNX) Reports Q3 Loss, Misses Revenue EstimatesZacks · Nov 5, 2026
- Merck's Remigromig Meets Main Goal in Diabetic Macular Edema StudyZacks · Sep 25, 2026
- Is Anika Therapeutics (ANIK) Outperforming Other Medical Stocks This Year?Zacks · Sep 25, 2026
The company
Anika Therapeutics, Inc. (NASDAQ: ANIK), is the global leader in the design, development, manufacturing, and commercialization of hyaluronic acid innovations. In partnership with clinicians, our primary focus is dedicated to delivering and advancing osteoarthritis pain management and orthopedic regenerative solutions. At our core is a passion to deliver a differentiated portfolio that improves patient outcomes around the world. Anika's global operations are headquartered outside of Boston, Massachusetts.
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- Exchange
- NASDAQ-GS
- Region
- North America
- Website
- anika.com
Often looked at with it
Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.